ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/03/11 | 4,425 | 4,445 | 4,090 | 4,095 | -395 | -8.8% | 1,262,200 |
2020/03/10 | 3,900 | 4,490 | 3,755 | 4,490 | +520 | +13.1% | 1,411,900 |
2020/03/09 | 4,220 | 4,245 | 3,925 | 3,970 | -435 | -9.9% | 941,200 |
2020/03/06 | 4,465 | 4,540 | 4,395 | 4,405 | -155 | -3.4% | 509,000 |
2020/03/05 | 4,555 | 4,575 | 4,475 | 4,560 | +110 | +2.5% | 612,000 |
2020/03/04 | 4,335 | 4,540 | 4,320 | 4,450 | +45 | +1% | 618,700 |
2020/03/03 | 4,625 | 4,635 | 4,405 | 4,405 | -85 | -1.9% | 861,800 |
2020/03/02 | 4,265 | 4,595 | 4,235 | 4,490 | +190 | +4.4% | 1,009,700 |
2020/02/28 | 4,390 | 4,440 | 4,200 | 4,300 | -180 | -4% | 1,508,100 |
2020/02/27 | 4,600 | 4,600 | 4,420 | 4,480 | -190 | -4.1% | 989,000 |
2020/02/26 | 4,775 | 4,800 | 4,605 | 4,670 | -140 | -2.9% | 706,900 |
2020/02/25 | 4,830 | 4,900 | 4,795 | 4,810 | -260 | -5.1% | 758,500 |
2020/02/21 | 5,170 | 5,200 | 5,050 | 5,070 | -120 | -2.3% | 482,200 |
2020/02/20 | 5,220 | 5,220 | 5,130 | 5,190 | +10 | +0.2% | 510,500 |
2020/02/19 | 5,010 | 5,230 | 4,970 | 5,180 | +180 | +3.6% | 641,700 |
2020/02/18 | 5,150 | 5,160 | 4,985 | 5,000 | -150 | -2.9% | 486,500 |
2020/02/17 | 5,250 | 5,310 | 5,120 | 5,150 | -100 | -1.9% | 510,200 |
2020/02/14 | 5,420 | 5,520 | 5,250 | 5,250 | -270 | -4.9% | 920,800 |
2020/02/13 | 5,500 | 5,560 | 5,480 | 5,520 | ±0 | ±0% | 416,300 |
2020/02/12 | 5,450 | 5,530 | 5,410 | 5,520 | +70 | +1.3% | 327,000 |
2020/02/10 | 5,370 | 5,490 | 5,360 | 5,450 | +50 | +0.9% | 384,100 |
2020/02/07 | 5,470 | 5,520 | 5,350 | 5,400 | -10 | -0.2% | 386,600 |
2020/02/06 | 5,400 | 5,440 | 5,340 | 5,410 | +50 | +0.9% | 372,300 |
2020/02/05 | 5,400 | 5,410 | 5,330 | 5,360 | +30 | +0.6% | 317,900 |
2020/02/04 | 5,260 | 5,330 | 5,240 | 5,330 | +110 | +2.1% | 348,000 |
2020/02/03 | 5,140 | 5,300 | 5,120 | 5,220 | -20 | -0.4% | 534,100 |
2020/01/31 | 5,270 | 5,320 | 5,240 | 5,240 | -50 | -0.9% | 403,700 |
2020/01/30 | 5,350 | 5,390 | 5,270 | 5,290 | -120 | -2.2% | 470,300 |
2020/01/29 | 5,420 | 5,440 | 5,370 | 5,410 | -40 | -0.7% | 286,800 |
2020/01/28 | 5,360 | 5,480 | 5,330 | 5,450 | +60 | +1.1% | 409,300 |
2020/01/27 | 5,340 | 5,420 | 5,300 | 5,390 | -70 | -1.3% | 298,900 |
2020/01/24 | 5,430 | 5,490 | 5,410 | 5,460 | ±0 | ±0% | 212,800 |
2020/01/23 | 5,550 | 5,550 | 5,430 | 5,460 | -120 | -2.2% | 445,100 |
2020/01/22 | 5,580 | 5,640 | 5,530 | 5,580 | -40 | -0.7% | 361,800 |
2020/01/21 | 5,660 | 5,710 | 5,580 | 5,620 | -90 | -1.6% | 336,400 |
2020/01/20 | 5,690 | 5,730 | 5,660 | 5,710 | +20 | +0.4% | 288,700 |
2020/01/17 | 5,760 | 5,760 | 5,650 | 5,690 | -30 | -0.5% | 338,000 |
2020/01/16 | 5,710 | 5,760 | 5,690 | 5,720 | +10 | +0.2% | 280,800 |
2020/01/15 | 5,700 | 5,750 | 5,650 | 5,710 | -30 | -0.5% | 311,300 |
2020/01/14 | 5,690 | 5,740 | 5,660 | 5,740 | +40 | +0.7% | 467,200 |
2020/01/10 | 5,610 | 5,710 | 5,580 | 5,700 | +110 | +2% | 357,400 |
2020/01/09 | 5,550 | 5,620 | 5,530 | 5,590 | +160 | +2.9% | 456,100 |
2020/01/08 | 5,410 | 5,470 | 5,330 | 5,430 | -70 | -1.3% | 566,100 |
2020/01/07 | 5,550 | 5,560 | 5,450 | 5,500 | +20 | +0.4% | 449,200 |
2020/01/06 | 5,500 | 5,530 | 5,460 | 5,480 | -120 | -2.1% | 528,300 |
2019/12/30 | 5,600 | 5,600 | 5,520 | 5,600 | -20 | -0.4% | 384,700 |
2019/12/27 | 5,640 | 5,680 | 5,610 | 5,620 | -40 | -0.7% | 318,700 |
2019/12/26 | 5,550 | 5,680 | 5,550 | 5,660 | +20 | +0.4% | 610,300 |
2019/12/25 | 5,650 | 5,690 | 5,610 | 5,640 | +50 | +0.9% | 560,700 |
2019/12/24 | 5,500 | 5,600 | 5,490 | 5,590 | +140 | +2.6% | 770,100 |
1251~
1300
件表示中 / 2899件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 187,600円 | +5.0% | +1.5% | 0.00% | 16.10倍 | 4.28倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 357,000円 | +7.9% | +8.9% | 3.47% | 7.64倍 | 1.02倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 62,700円 | +21.1% | - | 0.00% | 15.57倍 | 2.18倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
科研薬 | 410,900円 | +30.5% | +111.0% | 4.62% | 11.58倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 378,000円 | +14.5% | -2.3% | 2.38% | 13.83倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム